Breaking News Instant updates and real-time market news.

MSI

Motorola Solutions

$88.19

2.185 (2.54%)

, UAL

United Continental

$65.78

1.462 (2.27%)

09:55
10/06/17
10/06
09:55
10/06/17
09:55

Early notable gainers among liquid option names on October 6th

Notable gainers among liquid option names this morning include Motorola Solutions (MSI) $88.71 +2.74, United Continental (UAL) $65.69 +1.39, Vertex (VRTX) $155.38 +3.13, Southwest (LUV) $59.42 +1.14, and General Motors (GM) $44.60 +0.73.

MSI

Motorola Solutions

$88.19

2.185 (2.54%)

UAL

United Continental

$65.78

1.462 (2.27%)

VRTX

Vertex

$152.30

-0.21 (-0.14%)

LUV

Southwest

$58.94

0.65 (1.12%)

GM

General Motors

$44.55

0.7 (1.60%)

  • 24

    Oct

  • 06

    Nov

  • 07

    Nov

MSI Motorola Solutions
$88.19

2.185 (2.54%)

10/06/17
CLVD
10/06/17
UPGRADE
CLVD
Buy
Motorola Solutions upgraded to Buy from Neutral at Cleveland Research
05/26/17
JEFF
05/26/17
NO CHANGE
Target $100
JEFF
Buy
Jefferies feels 'very good' about risk/reward on Motorola Solutions
After looking into the company's business, Jefferies analyst George Notter says he feels "very good" about the risk/reward in shares of Motorola Solutions. The company is not seeing any slowdown in its Federal business, and management tends to set conservative expectations, Notter tells investors in a research note. He's still surprised that the guidance three weeks ago wasn't viewed more positively. The analyst reiterates a Buy rating on Motorola Solutions with a $100 price target.
05/30/17
NRCS
05/30/17
UPGRADE
NRCS
Buy
Motorola Solutions upgraded to Buy from Neutral at Northcoast
08/31/17
JEFF
08/31/17
NO CHANGE
Target $105
JEFF
Buy
Motorola Solutions meetings support positive view, says Jefferies
Jefferies analyst George Notter says meetings with management reinforce his positive view on Motorola Solutions. The analyst has a Buy rating on the shares with a $105 price target. The company's Public Safety/LMR radio systems are thus far operating extremely well in the Houston area, while the cellular/LTE network in that area is currently experiencing significant outages after Hurricane Harvey, Notter tells investors in a research note. He believes the storm highlights the difference in reliability of LMR sites versus LTE cell sites. Further, based on his conversations, Notter finds it likely that Motorola Solutions' Airwave contract in the United Kingdom will continue to get renewed going forward. Airwave is becoming a bigger focus for investors as the LMR network contract is set to expire on December 13, 2019, the analyst contends.
UAL United Continental
$65.78

1.462 (2.27%)

09/27/17
STFL
09/27/17
NO CHANGE
STFL
Big 4 airlines' exposure to Spirit lower than thought, says Stifel
Stifel analyst Joseph DeNardi believes that sell side analysts at other firms may be overstating the degree of overlap that the "Big 4" airlines - American Airlines (AAL), Delta (DAL), Southwest (LUV) and United Continental (UAL) - have with Spirit (SAVE) by not accurately adjusting to include only routes operated within the same time period as competitors. Adjusting to within a 2 hour time channel, he estimates only 5% of United's and Delta's total ASMs are directly exposed to Spirit, while 8% of American's ASMs and 11% of Southwest's are exposed, he tells investors. If United is hoping to influence Spirit's growth, it may choose to continue to compete aggressively, but if its goal is to improve margins, he would expect pricing to stabilize, DeNardi tells investors.
09/25/17
MACQ
09/25/17
INITIATION
Target $64
MACQ
Neutral
United Continental initiated with a Neutral at Macquarie
Macquarie analyst Susan Donofrio initiated American Airlines with a Neutral and $64 price target. The analyst believes management's focus on regaining lost domestic market share will likely lead to financial underperformance.
09/21/17
UBSW
09/21/17
NO CHANGE
UBSW
Recent correction in airline stocks overdone, says UBS
UBS analyst Darryl Genovesi noted that United Continental (UAL) and Alaska Air (ALK) are down about 20% while Delta (DAL) and American (AAL) have fallen about 10% so far in Q3 as the fare-matching narrative has re-surfaced and estimates for fuel costs have risen. However, he views the recent correction as overdone and thinks the airline group as a whole, which was cheap before, is cheaper now without the forward earnings growth outlook being any worse. Genovesi, who doesn't see evidence of a demand drop off in the travel agency data he tracks, thinks Q3 RASM weakness is predominantly "self-inflicted" by oversupply. Other publicly traded companies in the space include JetBlue (JBLU) and Southwest (LUV).
09/20/17
09/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) downgraded to Sell from Neutral at Goldman Sachs with analyst Jami Rubin saying pressure on key products combined with still-slow MD&D growth and continued strains on the consumer will leave the company with below average, long-term growth. 2. United Continental (UAL) downgraded to Market Perform at Raymond James with analyst Savanthi Syth saying an improvement in relative profitability versus legacy peers is likely to take longer than previously expected. 3. Ingersoll-Rand (IR) downgraded to Neutral from Overweight at JPMorgan with analyst C. Stephen Tusa saying he sees more relative upside and better risk/rewards elsewhere in the Electrical Equipment and Multi Industry sector. The analyst expects the company's solid execution to continue and raised his price target for the shares to $98 from $96. 4. L Brands (LB) downgraded to Market Perform from Outperform at Cowen with analyst Oliver Chen saying he sees risk to its comparable sales growth and margins if the company can not achieve elevated pricing. 5. Yahoo Japan (YAHOY) downgraded to Hold from Buy at Jefferies with analyst Hiroko Sato citing a lack of catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VRTX Vertex
$152.30

-0.21 (-0.14%)

09/26/17
LEER
09/26/17
NO CHANGE
Target $187
LEER
Outperform
ProQR Therapeutics QR-010 unlikely to challenge Vertex's medicines, says Leerink
Leerink analyst Geoffrey Porges notes that ProQR (PRQR) announced top line results from QR-010, an inhaled RNA oligonucleotide being studied as a disease modifying treatment in cystic fibrosis. The analyst says these results are confusing to interpret, but reinforce the high bar that Vertex (VRTX) has established with its recent cystic fibrosis breakthroughs. Porges believes QR-010 is unlikely to challenge Vertex's Medicines, and sees potential combination use. The analyst reiterates an Outperform rating and $187 price target on Vertex's shares.
09/07/17
LEER
09/07/17
NO CHANGE
LEER
Alexion, Celgene top picks at Leerink
Leerink analyst Geoffrey Porges notes large cap biotech stocks have performed strongly this year and have reversed some of the wide discount they were carrying compared to their history and to other medical products sectors. Further, he points out consensus revenue and earnings estimates for biotech companies have started to trend positively, after negative revisions earlier in the year. Porges still sees significant upside for many of the names in his coverage, and he anticipates that further appreciation can occur on the basis of recovering sentiment and multiples, further estimate revisions toward his current models, and confirmation of option value for unpriced pipeline opportunities. The analyst top picks are now Alexion (ALXN), Celgene (CELG), Regeneron (REGN), and Vertex (VRTX). Among his Market Perform rated stocks, his preference would be for AbbVie (ABBV).
09/14/17
RBCM
09/14/17
INITIATION
Target $175
RBCM
Outperform
Vertex initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Vertex Pharmaceuticals with an Outperform rating and $175 price target. The analyst is bullish on the company's cystic fibrosis triple combo and its long-term competitive positioning.
09/29/17
BTIG
09/29/17
INITIATION
Target $200
BTIG
Buy
Vertex initiated with a Buy at BTIG
BTIG analyst Dane Leone initiated Vertex (VRTX) with a Buy and $200 price target given its leadership position within the CFTR modulators for Cystic Fibrosis is unlikely to be challenged over the next 5-years, consensus estimates appear achievable through 2022 even with conservative assumptions regarding competition from AbbVie's (ABBV) Galapagos, and several interesting technology partnerships with companies such as CRISPR should start to unveil the deeper R&D pipeline during 2018.
LUV Southwest
$58.94

0.65 (1.12%)

09/25/17
MACQ
09/25/17
INITIATION
Target $62
MACQ
Outperform
Southwest initiated with an Outperform at Macquarie
Macquarie analyst Susan Donofrio Southwest with an Outperform and a $62 price target saying its well positioned to succeed given its focus on fare segmentation and a new reservation system amid an industry backdrop of widespread fare discounting.
09/25/17
MACQ
09/25/17
INITIATION
Target $62
MACQ
Outperform
Southwest initiated with an Outperform at Macquarie
Macquarie analyst Susan Donofrio initiated Southwest with an Outperform and $62 price target saying its well positioned to succeed given its focus on fare segmentation and a new reservation system amid an industry backdrop of widespread fare discounting.
10/06/17
DBAB
10/06/17
DOWNGRADE
Target $38
DBAB
Hold
Spirit Airlines downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Michael Linenberg downgraded Spirit Airlines (SAVE) to Hold and lowered his price target for the shares to $38 from $42. The company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets, Linenberg tells investors in a research note previewing September quarter earnings for Airlines. His favorite names in the sector are Delta Air Lines (DAL), American Airlines (AAL) and Southwest (LUV).
GM General Motors
$44.55

0.7 (1.60%)

10/06/17
SBSH
10/06/17
NO CHANGE
Target $53
SBSH
Buy
GM narrative shift could unlock 'much more' value, says Citi
Citi analyst Itay Michaeli attributes the recent rally in shares of General Motors to "short-term momentum into some future Investor Day/Event" as well as the start of "lasting re-rating." Taking a holistic second look at GM could "unlock substantially more value," Michaeli tells investors in a research note. The analyst believes GM's core auto segment is complemented by a leading RoboTaxi autonomous vehicle position. He believes this "narrative shift" could pave a path towards his prior long-term high-end upside potential case of $134 per share. Michaeli keeps a Buy rating on GM with a $53 price target.
10/05/17
RBCM
10/05/17
NO CHANGE
RBCM
Future of General Motors technology 'uncertain,' says RBC Capital
RBC Capital analyst Joseph Spak attributes the roughly 20% rally in GM stock since the end of August to investors' speculation about the value of the company's upcoming technology. The analyst says that it's "difficult to value" the company's tech initiatives. He ascribes no value to its EV business, saying that " EVs are just a change in propulsion and not a competitive advantage." Spak believes that the company's robo-taxi initiative has shown "good progress," but he thinks that it will face significant competition. Spak values GM's tech initiatives at about $6 per share, saying it will be some time before they are profitable. He raised his price target on the name to $44 from $38 but keeps a Sector Perform rating on the stock.
10/03/17
10/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy saying he has been pursuing expansion opportunities at an accelerating pace while maintaining its core truck and global auto business. 2. Phillips 66 (PSX) upgraded to Buy from Neutral at Goldman Sachs with analyst Neil Mehta saying he is positive on potential lower capital expenditures in 2018-2020 due to the roll off of major spending projects, sees underappreciated growth from the in-service of projects, and expects the company to benefit from a constructive outlook near-term for distillates. 3. Booz Allen (BAH) upgraded to Buy from Hold at Vertical Research. 4. Acuity Brands (AYI) upgraded to Market Perform from Underperform at JMP Securities with analyst Joseph Osha saying he believes consensus estimates are "behind the curve" and that the company should be able to protect its margins at current levels. 5. Regency Centers (REG) upgraded to Neutral from Underperform at Boenning & Scattergood. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
BOFA
10/03/17
UPGRADE
Target $57
BOFA
Buy
General Motors upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst John Murphy upgraded General Motors and increased its price target to $57 from $40. The analyst said has been pursuing expansion opportunities at an accelerating pace while maintaining its core truck and global auto business. Murphy believes General Motors has a first move advantage with its ability to integrate an autonomous electric vehicle into a ride hailing fleet and/or shared fleet enveloped with OnStar. This will allow General Motors to defend its current market share as the company pushes into creating a more valuable mobility product for consumers that will ultimately drive shareholder value, Murphy wrote in a note to investors.

TODAY'S FREE FLY STORIES

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

17:03
10/22/17
10/22
17:03
10/22/17
17:03
Conference/Events
OceanFirst Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

, SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

16:57
10/22/17
10/22
16:57
10/22/17
16:57
Conference/Events
Sun Bancorp to host special shareholder meeting »

Special Shareholder…

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Oct

  • 15

    Nov

SGU

Star Gas Partners, L.P.

$10.52

-0.16 (-1.50%)

16:49
10/22/17
10/22
16:49
10/22/17
16:49
Conference/Events
Star Gas Partners, L.P. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETRM

EnteroMedics

$2.05

0.07 (3.54%)

16:44
10/22/17
10/22
16:44
10/22/17
16:44
Conference/Events
EnteroMedics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

, SSB

South State

$92.15

-0.2 (-0.22%)

16:39
10/22/17
10/22
16:39
10/22/17
16:39
Conference/Events
South State to host special shareholder meeting »

Special Shareholder…

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

SSB

South State

$92.15

-0.2 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

SSB

South State

$92.15

-0.2 (-0.22%)

, PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

16:36
10/22/17
10/22
16:36
10/22/17
16:36
Conference/Events
Park Sterling Bank to host special shareholder meeting »

Special Shareholder…

SSB

South State

$92.15

-0.2 (-0.22%)

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

, CARO

Carolina Financial

$36.17

0.23 (0.64%)

16:22
10/22/17
10/22
16:22
10/22/17
16:22
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

CARO

Carolina Financial

$36.17

0.23 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CARO

Carolina Financial

$36.17

0.23 (0.64%)

, FSBK

First South Bancorp

$18.66

0.14 (0.76%)

16:19
10/22/17
10/22
16:19
10/22/17
16:19
Conference/Events
First South Bancorp to host special shareholder meeting »

Special Shareholder…

CARO

Carolina Financial

$36.17

0.23 (0.64%)

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

13:41
10/22/17
10/22
13:41
10/22/17
13:41
Periodicals
Fox knew of new harassment settlement before signing O'Reilly, Reuters says »

Forced to resign in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TM

Toyota

$123.71

0.64 (0.52%)

13:37
10/22/17
10/22
13:37
10/22/17
13:37
Periodicals
Toyota to halt operations at Japan plants as typhoon approaches, Reuters says »

Toyota is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

, BAC

Bank of America

$27.17

0.59 (2.22%)

13:34
10/22/17
10/22
13:34
10/22/17
13:34
Hot Stocks
IntercontinentalExchange completes BofA Merrill's Index Platform acquisition »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

BAC

Bank of America

$27.17

0.59 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

VCYT

Veracyte

$9.30

0.11 (1.20%)

13:30
10/22/17
10/22
13:30
10/22/17
13:30
Hot Stocks
Veracyte announces new data, highlights Afirma GSC performance »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$63.88

0.13 (0.20%)

13:19
10/22/17
10/22
13:19
10/22/17
13:19
Hot Stocks
Study shows Merck Zepatier resulted in high sustained virologic response rates »

Merck has announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

  • 02

    Feb

EADSY

Airbus

$23.76

-0.135 (-0.56%)

, BDRBF

Bombardier

$2.25

0.04 (1.81%)

12:57
10/22/17
10/22
12:57
10/22/17
12:57
Periodicals
Airbus turmoil overshadows bid to rescue Bombardier CSeries, Reuters says »

Airbus's (EADSY)…

EADSY

Airbus

$23.76

-0.135 (-0.56%)

BDRBF

Bombardier

$2.25

0.04 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

, SPX

S&P 500

11:19
10/22/17
10/22
11:19
10/22/17
11:19
Periodicals
Senate Republican Leader says tax bill to be revenue neutral, Reuters reports »

Mitch McConnell said he…

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$15.56

0.31 (2.03%)

11:15
10/22/17
10/22
11:15
10/22/17
11:15
Periodicals
People use Snapchat at parties, not as much at sports stadiums, Recode says »

There seems to be a huge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

11:09
10/22/17
10/22
11:09
10/22/17
11:09
Periodicals
Tesla reaches deal for Shanghai manufacturing facility, WSJ reports »

Tesla has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

, UNH

UnitedHealth

$207.49

4.24 (2.09%)

11:01
10/22/17
10/22
11:01
10/22/17
11:01
Periodicals
Senator McConnell waiting for Trump's OK on healthcare bill, Reuters says »

Republican Senate Leader…

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

CNC

Centene

$96.50

1.8 (1.90%)

WCG

WellCare

$180.52

3.28 (1.85%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

AET

Aetna

$160.84

3.2 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

10:57
10/22/17
10/22
10:57
10/22/17
10:57
Periodicals
Tesla expects to agree on deal to build cars in China by year-end, Reuters says »

Tesla is talking with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.